Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.

PubWeight™: 3.42‹?› | Rank: Top 1%

🔗 View Article (PMID 16373758)

Published in Radiology on January 01, 2006

Authors

Mitchell D Schnall1, Jeffrey Blume, David A Bluemke, Gia A DeAngelis, Nanette DeBruhl, Steven Harms, Sylvia H Heywang-Köbrunner, Nola Hylton, Christiane K Kuhl, Etta D Pisano, Petrina Causer, Stuart J Schnitt, David Thickman, Carol B Stelling, Paul T Weatherall, Constance Lehman, Constantine A Gatsonis

Author Affiliations

1: Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, USA. Mitchell.Schnall@uphs.upenn.edu

Articles citing this

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA (2008) 10.92

The ACR BI-RADS experience: learning from history. J Am Coll Radiol (2009) 2.68

Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology (2010) 2.58

Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol (2008) 2.52

Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology (2010) 1.86

Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment. AJR Am J Roentgenol (2009) 1.52

Positive predictive value of BI-RADS MR imaging. Radiology (2012) 1.46

Textural kinetics: a novel dynamic contrast-enhanced (DCE)-MRI feature for breast lesion classification. J Digit Imaging (2011) 1.43

Image standards in tissue-based diagnosis (diagnostic surgical pathology). Diagn Pathol (2008) 1.39

Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology (2010) 1.33

Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer (2010) 1.26

Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol (2009) 1.24

Optimization of a dual-energy contrast-enhanced technique for a photon-counting digital breast tomosynthesis system: I. A theoretical model. Med Phys (2010) 1.20

Dual-energy contrast-enhanced digital breast tomosynthesis--a feasibility study. Br J Radiol (2009) 1.17

Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol (2009) 1.17

A review of breast tomosynthesis. Part II. Image reconstruction, processing and analysis, and advanced applications. Med Phys (2013) 1.14

STEP: spatiotemporal enhancement pattern for MR-based breast tumor diagnosis. Med Phys (2009) 1.08

Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging (2009) 1.05

Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer (2009) 1.02

3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol (2011) 1.01

Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol (2010) 1.00

Segmentation and classification of breast tumor using dynamic contrast-enhanced MR images. Med Image Comput Comput Assist Interv (2007) 1.00

A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. Magn Reson Imaging (2012) 1.00

Current approaches and challenges in early detection of breast cancer recurrence. J Cancer (2014) 1.00

Computer-aided detection in breast MRI: a systematic review and meta-analysis. Eur Radiol (2011) 1.00

Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol (2010) 0.99

Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol (2010) 0.99

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. Eur Radiol (2008) 0.96

Computerized three-class classification of MRI-based prognostic markers for breast cancer. Phys Med Biol (2011) 0.96

High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol (2011) 0.95

Dedicated breast computed tomography: the optimal cross-sectional imaging solution? Radiol Clin North Am (2010) 0.95

Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis. Eur Radiol (2014) 0.95

Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys (2013) 0.94

Fourier component imaging of water resonance in the human breast provides markers for malignancy. Phys Med Biol (2009) 0.93

Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage. Magn Reson Imaging (2009) 0.92

Combined reading of Contrast Enhanced and Diffusion Weighted Magnetic Resonance Imaging by using a simple sum score. Eur Radiol (2015) 0.92

Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol (2012) 0.92

Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers. Acad Radiol (2010) 0.91

In vivo MRI of early stage mammary cancers and the normal mouse mammary gland. NMR Biomed (2011) 0.90

The effect of scatter and glare on image quality in contrast-enhanced breast imaging using an a-Si/CsI(TI) full-field flat panel detector. Med Phys (2009) 0.88

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. Eur Radiol (2008) 0.88

Pearls and pitfalls in breast MRI. Br J Radiol (2011) 0.87

The effects of applying breast compression in dynamic contrast material-enhanced MR imaging. Radiology (2014) 0.86

Extra-mammary findings in breast MRI. Eur Radiol (2011) 0.86

The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging (2011) 0.84

Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics. Eur Radiol (2011) 0.84

Molecular Imaging in Breast Cancer - Potential Future Aspects. Breast Care (Basel) (2011) 0.83

A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol (2013) 0.83

Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers. AJR Am J Roentgenol (2013) 0.82

Feature selection in computer-aided breast cancer diagnosis via dynamic contrast-enhanced magnetic resonance images. J Digit Imaging (2013) 0.82

Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions. Exp Ther Med (2014) 0.81

Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications. PLoS One (2014) 0.81

Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Oncologist (2013) 0.80

Spectral embedding based active contour (SEAC) for lesion segmentation on breast dynamic contrast enhanced magnetic resonance imaging. Med Phys (2013) 0.80

Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions. Acad Radiol (2014) 0.80

Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit. Eur Radiol (2010) 0.79

Role of quantitative pharmacokinetic parameter (transfer constant: K(trans)) in the characterization of breast lesions on MRI. Indian J Radiol Imaging (2013) 0.79

Features of occult invasion in biopsy-proven DCIS at breast MRI. Breast J (2013) 0.79

Clinical outcome of magnetic resonance imaging-detected additional lesions in breast cancer patients. J Breast Cancer (2011) 0.78

Contribution of kinetic characteristics of axillary lymph nodes to the diagnosis in breast magnetic resonance imaging. Balkan Med J (2012) 0.78

Investigating the influence of flip angle and k-space sampling on dynamic contrast-enhanced MRI breast examinations. Acad Radiol (2014) 0.78

Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast. Iran J Radiol (2016) 0.78

Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality. Invest Radiol (2016) 0.78

Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity. J Magn Reson Imaging (2016) 0.78

Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison. Eur Radiol (2015) 0.77

Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis. Eur Radiol (2015) 0.77

Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors. Eur Radiol (2011) 0.77

Segmental enhancement on breast MR images: differential diagnosis and diagnostic strategy. Eur Radiol (2008) 0.77

The added diagnostic value of dynamic contrast-enhanced MRI at 3.0 T in nonpalpable breast lesions. PLoS One (2014) 0.77

Breast MR Imaging: What the Radiologist Needs to Know. J Clin Imaging Sci (2011) 0.75

Kinetic Curve Type Assessment for Classification of Breast Lesions Using Dynamic Contrast-Enhanced MR Imaging. PLoS One (2016) 0.75

MRI-guided breast biopsy: outcomes and effect on patient management. Clin Breast Cancer (2014) 0.75

A method for limiting pitfalls in the production of enhancement kinetic curves in 3T dynamic magnetic resonance mammography. J Thorac Dis (2012) 0.75

Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine. Magn Reson Imaging Clin N Am (2015) 0.75

Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography? Br J Radiol (2016) 0.75

The Role of MR Mammography in Differentiating Benign from Malignant in Suspicious Breast Masses. J Clin Diagn Res (2016) 0.75

Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer. Medicine (Baltimore) (2016) 0.75

Takeaways from Pre-Contrast T1 and T2 Breast Magnetic Resonance Imaging in Women with Recently Diagnosed Breast Cancer. Iran J Radiol (2016) 0.75

A New Septum in the Female Breast. Arch Plast Surg (2017) 0.75

Accuracy of the Fischer scoring system and the Breast Imaging Reporting and Data System in identification of malignant breast lesions. Ann Saudi Med (2009) 0.75

Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort. J Magn Reson Imaging (2016) 0.75

Dynamic breast MR imaging: is parametric mapping superior to image subtraction in lesion detection? Eur Radiol (2007) 0.75

Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity. Eur Radiol (2016) 0.75

Articles by these authors

Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA (2008) 10.92

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ (2003) 10.80

MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med (2007) 10.28

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem (2003) 8.13

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71

Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol (2006) 6.13

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med (2008) 5.86

Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med (2010) 5.70

Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology (2008) 5.59

Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation (2007) 5.09

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA (2012) 4.25

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13

Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation (2002) 4.11

A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell (2007) 3.97

Magnetic resonance imaging of the breast prior to biopsy. JAMA (2004) 3.97

Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87

Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med (2008) 3.76

Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation (2004) 3.38

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36

Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol (2006) 3.33

A non-genetic route to aneuploidy in human cancers. Nat Cell Biol (2011) 3.25

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res (2007) 3.08

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol (2008) 2.99

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract (2004) 2.99

Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J Am Coll Cardiol (2006) 2.94

Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation (2005) 2.94

Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation (2010) 2.89

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. J Clin Oncol (2012) 2.85

Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst (2004) 2.84

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med (2008) 2.83

Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm (2009) 2.82

A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med (2011) 2.81

Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation (2005) 2.80

Adenosine stress 64- and 256-row detector computed tomography angiography and perfusion imaging: a pilot study evaluating the transmural extent of perfusion abnormalities to predict atherosclerosis causing myocardial ischemia. Circ Cardiovasc Imaging (2009) 2.80

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2004) 2.78

Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 2.74

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat (2011) 2.73

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology (2003) 2.73

Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation (2006) 2.69

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res (2008) 2.69

The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging (2010) 2.69

Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med (2013) 2.66

Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol (2012) 2.65

Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging (2008) 2.64

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62

Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation (2007) 2.61

Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol (2004) 2.59

Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. Cancer (2004) 2.56

Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the Multi-Ethnic Study of Atherosclerosis. Circulation (2005) 2.54

The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2009) 2.53

Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging (2009) 2.51

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology (2009) 2.48

Volume-preserving nonrigid registration of MR breast images using free-form deformation with an incompressibility constraint. IEEE Trans Med Imaging (2003) 2.44

Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol (2009) 2.44

American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology. Radiology (2005) 2.42

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol (2010) 2.42

Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 2.40

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38

Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation (2006) 2.36

Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol (2005) 2.36

Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res (2010) 2.33

Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol (2005) 2.30

Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson (2011) 2.30

Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation (2011) 2.30

Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2013) 2.29

Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation (2008) 2.28

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer (2005) 2.25

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23

Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet (2009) 2.19

High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the multiethnic study of atherosclerosis. Am Heart J (2012) 2.18